0
0
0
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury and the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond".
12/29/2022, 10:48 PM
Summary of Bill SJRES 43
Bill 117 SJRes 43 is a joint resolution that aims to disapprove of a rule submitted by the Department of the Treasury and the Centers for Medicare & Medicaid Services regarding the Patient Protection and Affordable Care Act. The rule in question pertains to updating payment parameters, implementing regulations for Section 1332 waivers, and improving health insurance markets for the year 2022 and beyond.
The resolution falls under chapter 8 of title 5 of the United States Code, which allows Congress to review and potentially overturn regulations proposed by federal agencies. In this case, the resolution seeks to reject the rule put forth by the Department of the Treasury and the Centers for Medicare & Medicaid Services.
The resolution is non-partisan in nature and aims to provide a thoughtful analysis of the potential impact of the proposed rule on the healthcare system in the United States. It is written in a way that is accessible to 10th grade level readers, making it easier for the general public to understand the complexities of healthcare policy and regulation. Overall, Bill 117 SJRes 43 is an important piece of legislation that highlights the role of Congress in overseeing and regulating federal agency actions. It underscores the need for transparency and accountability in the rulemaking process, particularly when it comes to critical issues such as healthcare reform.
The resolution falls under chapter 8 of title 5 of the United States Code, which allows Congress to review and potentially overturn regulations proposed by federal agencies. In this case, the resolution seeks to reject the rule put forth by the Department of the Treasury and the Centers for Medicare & Medicaid Services.
The resolution is non-partisan in nature and aims to provide a thoughtful analysis of the potential impact of the proposed rule on the healthcare system in the United States. It is written in a way that is accessible to 10th grade level readers, making it easier for the general public to understand the complexities of healthcare policy and regulation. Overall, Bill 117 SJRes 43 is an important piece of legislation that highlights the role of Congress in overseeing and regulating federal agency actions. It underscores the need for transparency and accountability in the rulemaking process, particularly when it comes to critical issues such as healthcare reform.
Congressional Summary of SJRES 43
This joint resolution nullifies the rule titled Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond, which was issued by the Centers for Medicare & Medicaid Services and the Department of the Treasury on September 27, 2021. The rule expands the open enrollment period for individual health coverage and rescinds the previous interpretation of certain requirements relating to Section 1332 waivers (also known as State Innovation Waivers or State Relief and Empowerment Waivers).
Read the Full Bill
Current Status of Bill SJRES 43
Bill SJRES 43 is currently in the status of Bill Introduced since March 23, 2022. Bill SJRES 43 was introduced during Congress 117 and was introduced to the Senate on March 23, 2022. Bill SJRES 43's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 23, 2022
Bipartisan Support of Bill SJRES 43
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
64Democrat Cosponsors
0Republican Cosponsors
64Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill SJRES 43
Primary Policy Focus
HealthPotential Impact Areas
- Administrative law and regulatory procedures
- Congressional oversight
- Department of Health and Human Services
- Health care costs and insurance
- Health care coverage and access
- User charges and fees
Alternate Title(s) of Bill SJRES 43
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury and the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond".
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury and the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond".
Comments
Sponsors and Cosponsors of SJRES 43
Latest Bills
HEATS Act
Bill HR 5587July 31, 2026
HEATS Act
Bill S 4975July 31, 2026
CLEAN Act
Bill HR 1687July 31, 2026
CLEAN Act
Bill S 4960July 31, 2026
Biosimilar Red Tape Elimination Act
Bill S 1954July 31, 2026
Summer Meals REACH Act of 2026
Bill HR 9587July 31, 2026
Kayleigh’s Law Act of 2026
Bill HR 8481July 31, 2026
Cannabis Administration and Opportunity Act
Bill S 5022July 31, 2026
Duster Inhalation Prevention Act
Bill S 5002July 31, 2026
ACCESS Rural America Act
Bill S 5003July 31, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury and the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing Regulations, and Improving Health Insurance Markets for 2022 and Beyond".
Bill HJRES 79December 29, 2022





